3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor
Interventions
pembrolizumab
11
Nivolumab
6
fludarabine phosphate
5
fludarabine
5
Paclitaxel
5
Cyclophosphamide
5
Cisplatin
5
Cetuximab
5
Carboplatin
5
atezolizumab
4
Specimen Handling
4
Pemetrexed
4
Docetaxel
4
Bevacizumab
4
durvalumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
venetoclax
2
temsirolimus
2
niraparib
2
ibrutinib
2
enzalutamide
2
encorafenib
2
binimetinib
2
Trastuzumab
2
Taxes
2
Standard of Care
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Terminated
×
Maximum Tolerated Dose
×
30 days
×
Clear all
No trials found.